Instradent strengthens foothold in emerging Asian markets

  • Instradent to acquire approximately 43% of T-Plus, a leading dental implant company in Taiwan
  • T-Plus dental implant system has regulatory clearance in China
  • Agreement paves the way for Instradent to take control of T-Plus in 2018
  • Injection of capital will accelerate T-Plus' growth strategy and international expansion plans

Basel/Tapei, 24 November 2014: Instradent, an international provider of attractively-priced tooth replacement solutions, and the major shareholders of T-Plus, a dental implant company based in Taiwan, have signed an agreement allowing Instradent to acquire approximately 43% of T-Plus in March/April 2015. Instradent also has the option of increasing its stake up to 90% 2020. The agreement, which is subject to approval by the Taiwan Investment Commission, includes an option that paves the way for Instradent to take control of T-Plus in 2018.

T-Plus addresses Instradent's need for a low-cost partner based in Asia with an established presence in Taiwan and access to the value segment of the fast-growing Chinese market. T-Plus has regulatory clearance to sell its implants on mainland China and plans to invest the majority of the transaction proceeds in the expansion of its domestic and international implant business.

Marco Gadola, Chairman of the Board of Instradent, explained the rationale for the transaction: "Instradent is building up a global distribution platform with the aspiration of becoming a global leader in the value segment of the tooth replacement market. We are investing in successful local brands and helping them to expand internationally. T-Plus has the products, regulatory clearance and customer proximity to penetrate the fast-growing value segment in China and is well positioned to succeed."

About T-Plus

Located in the Wugu District of New Taipei City, T-Plus Implant Tech. Co. Ltd. was established in 2008 and is owned by 77 shareholders - including the three founding shareholders, who hold 84% of the shares. Its portfolio includes the cost-effective Ti-Star and A+ ranges of implants, which are sold in Taiwan. In addition to approvals from Taiwan's TFDA, the company has the following certifications: GMP, European CE, China's CFDA, US FDA 510(k), and ISO 13485 for medical equipment manufacturing.

About Instradent

Instradent was established in 2014 as a business platform to drive and manage the distribution and internationalization of specific brands for tooth replacement solutions, offering high quality, attractively-priced products, which are very popular in domestic and regional markets. Instradent's goal is tomake them available to dental professionals internationally through its own growing network. Instradent has country organizations in the USA, Iberia, Germany and Italy. Instradent is a lean organization, set-up to deliver superior quality at highly competitive prices and maximum customer convenience.


Press release download



Provider
Channel
Contact
Tensid Ltd., Switzerland
www.tensid.ch


newsbox.ch
www.newsbox.ch


Provider/Channel related enquiries
marco@tensid.ch
+41 41 763 00 50